Drug Profile
Research programme: incretin stimulants - Surface Logix
Alternative Names: SLx-6677Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Surface Logix
- Class Small molecules
- Mechanism of Action Gastric inhibitory polypeptide stimulants; Incretin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Metabolic disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Metabolic-disorders in USA
- 12 Apr 2011 Surface Logix has been acquired by Nano Terra